Literature DB >> 12867985

Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.

Anshu Agrawal1, Jai Lingappa, Stephen H Leppla, Sudhanshu Agrawal, Abdul Jabbar, Conrad Quinn, Bali Pulendran.   

Abstract

Anthrax poses a clear and present danger as an agent of biological terrorism. Infection with Bacillus anthracis, the causative agent of anthrax, if untreated can result in rampant bacteraemia, multisystem dysfunction and death. Anthrax lethal toxin (LT) is a critical virulence factor of B. anthracis, which occurs as a complex of protective antigen and lethal factor. Here we demonstrate that LT severely impairs the function of dendritic cells--which are pivotal to the establishment of immunity against pathogens--and host immune responses by disrupting the mitogen-activated protein (MAP) kinase intracellular signalling network. Dendritic cells exposed to LT and then stimulated with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amounts of proinflammatory cytokines, and do not effectively stimulate antigen-specific T cells in vivo. Furthermore, injections of LT induce a profound impairment of antigen-specific T- and B-cell immunity. These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867985     DOI: 10.1038/nature01794

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  115 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.

Authors:  Celia M Ebrahimi; Tamsin R Sheen; Christian W Renken; Roberta A Gottlieb; Kelly S Doran
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 3.  Exposing a killer: pathologists angle for anthrax.

Authors:  Stephen W Chensue
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

4.  MAPping innate immunity.

Authors:  John A T Young; Andrew Dillin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

5.  An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.

Authors:  Nam-Kyu Lim; Jung-Hwan Kim; Mee Sook Oh; Sangyoon Lee; Se-Yeon Kim; Keun-Soo Kim; Hyun-Jung Kang; Hyo Jeong Hong; Kyung-Soo Inn
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Receptor-specific requirements for anthrax toxin delivery into cells.

Authors:  G Jonah A Rainey; Darran J Wigelsworth; Patricia L Ryan; Heather M Scobie; R John Collier; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

7.  Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Authors:  Biswanath Majumder; Michelle L Janket; Elizabeth A Schafer; Keri Schaubert; Xiao-Li Huang; June Kan-Mitchell; Charles R Rinaldo; Velpandi Ayyavoo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Histopathology in a murine model of anthrax.

Authors:  Scott Duong; Lucius Chiaraviglio; James E Kirby
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

9.  Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila.

Authors:  Lakshmi Pillai; Jian Sha; Tatiana E Erova; Amin A Fadl; Bijay K Khajanchi; Ashok K Chopra
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

10.  Effect of Bacillus anthracis virulence factors on human dendritic cell activation.

Authors:  Andrew C Hahn; C Rick Lyons; Mary F Lipscomb
Journal:  Hum Immunol       Date:  2008-07-26       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.